This article situates the ethical function of health within contemporary deregulation, as a broad governing logic focused on individual entrepreneurial freedom. The article presents three US-based case studies that resonate internationally and are positioned across the health spectrum, examining a blood diagnostic company, a popular wellness brand, and conspiratorial health influencers. The author develops the framework of deregulatory folkway to underscore the way deregulation in health (1) stratifies the population, as a means of generating value and profits; and (2) justifies inequality in terms of exceptional individuals, enterprising companies, salvific campaigns, and other claims on the future. The case studies foreground three specific deregulatory folkways — disruption, aspiration, and awakening — that the author scrutinizes as extractive and complicit in guiding health toward individualized entitlement, possessive freedom, and transactional relations with the human body. The triptych reveals a process of value creation — of generating capital (economic, political, social, bodily) — that promises better health awareness, efficiency, enlightenment, even life expectancy, yet depends on and deepens inequality. The article ends by positing political care for interdependency — health as solidarity — against the myth of the individual and deregulation's cynical endorsement of ongoing gendered racialized ills.
No takes yet. Share an insight, caveat, or question.
Shiloh Krupar (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: